Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome.
Yinli ZhangYongpeng GeHanbo YangHe ChenXiaolan TianZhenguo HuangShengyun LiuXin LuGuo-Chun WangPublished in: Clinical rheumatology (2020)
Anti-EJ syndrome was found to be a relatively common ASS subtype, with a favorable outcome. A notable proportion of the patients experienced RP-ILD, which was prone to OP on HRCT and a higher CAR, and needed aggressive management. Key Points • ILD was the most common initial manifestation of anti-glycyl tRNA synthetase syndrome. • RP-ILD was notable in anti-EJ positive patients. • Anti-EJ positive patients possessed a favorable long-term prognosis, but easily relapsed.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- prognostic factors
- type diabetes
- metabolic syndrome
- rheumatoid arthritis
- acute myeloid leukemia
- case report
- insulin resistance
- adipose tissue
- systemic sclerosis
- patient reported
- diffuse large b cell lymphoma
- multiple myeloma
- hodgkin lymphoma